Related Experiment Video

Updated: Aug 7, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to

Angelo J Russo1, Pellegrino G Magro, Zhen Hu

  • 1The Cancer Institute of New Jersey, Robert Wood Johnson School of Medicine, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey 08903, USA.

Cancer Research
|July 20, 2006
PubMed

Insights

Overexpressing E2F-1 increases sensitivity to mitotic drugs like paclitaxel by upregulating cyclin B1 and cdc2 kinase, suggesting potential for targeted cancer therapy.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • E2F transcription factors regulate genes for cell cycle progression.
  • Retinoblastoma protein (pRB) normally restrains E2F activity.
  • E2F-1 is crucial for the G1-S phase transition.

Purpose of the Study:

  • Investigate E2F-1's impact on chemotherapy drug cytotoxicity.
  • Explore E2F-1's role in cell cycle regulation, particularly G2-M phase.
  • Determine if E2F-1 overexpression affects sensitivity to mitotic inhibitors.

Main Methods:

  • Used a tetracycline-inducible E2F-1 U2OS osteosarcoma cell line.
  • Assessed cytotoxicity of various chemotherapeutic agents.
  • Measured cyclin B1 and cdc2 kinase activity upon E2F-1 induction.
  • Utilized RNA interference for cyclin B1 knockdown.

Main Results:

  • E2F-1 overexpression did not alter sensitivity to doxorubicin, cisplatin, 5-FU, or etoposide.
  • Increased sensitivity to vinblastine and paclitaxel observed with E2F-1 overexpression.
  • E2F-1 induction led to increased cyclin B1 mRNA, protein, and cdc2 kinase activity.
  • Cyclin B1 overexpression enhanced paclitaxel sensitivity; knockdown increased resistance.

Conclusions:

  • E2F-1 influences sensitivity to mitotic drugs.
  • E2F-1 regulates genes involved in mitotic entry and exit.
  • Mitotic inhibitors may selectively target tumors overexpressing E2F-1.

More Related Videos

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk113:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

An Electroporation Cytometry Protocol for Live-Cell, Fluorescence Microscopy Using U2 OS Cell Culture06:01

An Electroporation Cytometry Protocol for Live-Cell, Fluorescence Microscopy Using U2 OS Cell Culture

Published on: June 13, 2025

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Meiosis II02:02

Meiosis II

Meiosis II entails cell division and segregation of the sister chromatids, resulting in the production of four unique haploid gametes. The steps for meiosis II are similar to mitosis, except that meiosis II occurs in haploid cells, whereas mitosis occurs in diploid cells.
The timing and cell division patterns of meiosis differ between males and females. In male meiosis, the centrosomes are part of the formation of the meiotic spindle. However, in oocytes, including that of humans, Drosophila,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...